Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlamydia Screening and Treatment in Pregnant Women
NCT03862495Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2020
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of azithromycin in Chlamydia trachomatis infection (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Response Rate at Recruitment, Compliance to Receive CT or NG Treatment and 2 more. Started May 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on NCT03862495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862495.